The Ozempic Flip-Flop
December 13, 2024

(The Atlantic) – West Virginia gave obesity drugs to teachers and state employees—then took them away.
The program was, by health measures, a success. Patients shed as much as 120 pounds, their cholesterol dropped, their prediabetes faded, and they cut down on blood-pressure meds. As word began to spread, more patients wanted to join. A school nurse told me her weight loss inspired at least six other teachers and staff to get into the pilot program too.
Then it all came to an abrupt end. In March, the state’s Public Employee Insurance Agency (PEIA) decided it could no longer bear the crushing costs of Wegovy and Zepbound. (Read More)